Cite
MLA Citation
Jameel Abdulrehman et al.. “Safety of idarucizumab in the reversal of dabigatran at six tertiary care Ontario hospitals.” Research and practice in thrombosis and haemostasis, vol. 5, no. 5, 2021, p. n/a. http://access.bl.uk/ark:/81055/vdc_100140215636.0x000002